David C. Rees
38 works · 4,057 citations · h-index 17
Top works
- Fragment-based lead discovery
- A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host The discovery of Org 25969 is the result of teamwork with contributions from a number of scientists both inside Organon and outside the company. We would like in particular to acknowledge the following scientists for their invaluable contributions: E. Hutchinson, D. Stevenson, R. Roy, and J. Pick for scaling-up the synthesis; F. Hope, S. Miller, and R. Mason for various in vitro and in vivo pharmacological testing; R. Watson, B. Montgomery, P. Desmond, and A. Osprey for all their analytical effort; and R. McGuire and J. Mestres for graphical presentation of the X-ray crystal structure of the Org 25969–rocuronium complex (Figure 3). We would also like to thank Prof. A. Cooper of Glasgow University who has critically reproduced our calorimetry data of Org 25969–rocuronium complexation (Figure 2).
- Organic synthesis provides opportunities to transform drug discovery
- A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host
- Cyclodextrin-Derived Host Molecules as Reversal Agents for the Neuromuscular Blocker Rocuronium Bromide: Synthesis and Structure−Activity Relationships
- Experiences in fragment-based drug discovery
- Opportunity Knocks: Organic Chemistry for Fragment‐Based Drug Discovery (FBDD)
- A review of recent applications of cyclodextrins for drug discovery
- Chapter 28 Fragment-Based Lead Discovery
- Anionic Cyclophanes as Potential Reversal Agents of Muscle Relaxants by Chemical Chelation
- α-Chloronitroso compounds derived from carbohydrate ketones: cycloadditions with cyclic dienes, a synthesis of (−)-physoperuvine and a formal synthesis of (+)-epibatidine
- Fragment-to-Lead Medicinal Chemistry Publications in 2015
- Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors
- Fragment-based drug discovery: opportunities for organic synthesis
- Fragment-to-Lead Medicinal Chemistry Publications in 2016
- Organische Chemie für die fragmentbasierte Wirkstoffentwicklung (FBDD)
- C–H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD)
- Introduction to the themed collection on fragment-based drug discovery
- Medicines for millions of patients
- ChemInform Abstract: Anionic Cyclophanes as Potential Reversal Agents of Muscle Relaxants by Chemical Chelation.